Maybe a chance for secondary data sets as Leo suggested more data will be released I think in intervals for OM as the get it, so maybe we get duration times? But I don’t expect much. I did enjoy the PR stating they are not only presenting at the biotech but also attending the big boy one across the street. They never told us that before.....
It’s more likely there will be more details, especially bottom line info not yet released. For example, OM duration and severity reduction could be released, or details for IBD and UP results.
News 
Market Data 
Discover 
